LED Dental Inc.

LED Dental Inc.

June 05, 2013 07:00 ET

MEDIA ADVISORY: Experts Available to Speak About Oral Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 5, 2013) - LED Dental Inc., a Canadian manufacturer of tissue fluorescence visualization technology for the early detection of oral cancer, announces that its CEO, Peter Whitehead as well as its CTO, David Morgan are available to the media to comment on oral cancer, its growing prevalence in North America and its link to the spread of Human Papillomavirus ("HPV").


  • The growing incidence of oral cancer in North America;

  • The changing behaviours of oral cancer due to HPV, including the alarming shift in demographics to young, non-smokers;

  • The science of tissue fluorescence visualization for early detection of oral cancer and pre-cancer - often years before the disease can be detected with the naked eye.


LED Dental Inc. manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used by more than 13,000 dentists in 23 countries to conduct screenings for oral cancer, pre-cancer and other oral tissue abnormalities. Over 25 million exams have been performed using the VELscope® Vx and countless lives have been saved as a result of this technology. For more information, visit www.leddental.com.

LED Dental is a wholly-owned subsidiary of LED Medical Diagnostics Inc., a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com.

Contact Information